{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-031247","form_type":"8-K","ticker":"INBP","cik":"0001016504","company_name":"INTEGRATED BIOPHARMA INC","filed_at":"2026-09-25T21:05:32+00:00","discovered_at":"2026-09-25T21:08:00.307599+00:00","generated_at":"2026-10-12T13:26:48.937719+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Integrated BioPharma FY2026 revenue falls 19.3% to $43.9M; swings to $2.8M net loss from $0.8M income","bullets":["Q4 revenue $9.8M vs $14.2M a year earlier, down $4.4M or 31.0%; Q4 operating loss $0.9M vs $0.6M operating income.","FY2026 operating loss ~$2.7M vs FY2025 operating income $2.0M; Q4 gross profit collapsed to $28K from $1.47M.","FY net loss ~$2.8M (-$0.09/share) vs FY2025 net income ~$0.8M ($0.03/share); Q4 net loss ~$1.4M (-$0.04 vs -$0.01).","Co-CEOs Riva Sheppard and Christina Kay: two largest Contract Manufacturing customers were ~90% of FY2026 revenue, up from 84% in FY2025.","FY2026 income tax expense of $0.3M recorded despite pre-tax loss of $2.6M; weighted average shares 31.06M."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-031247","json":"https://secwatch.observer/filing/0001437749-26-031247.json","markdown":"https://secwatch.observer/filing/0001437749-26-031247.md","text":"https://secwatch.observer/filing/0001437749-26-031247.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1016504/000143774926031247/0001437749-26-031247-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1016504/000143774926031247/inbp20260925_8k.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-12T13:26:48.937719+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}